ANN SWEZEY: Open Payments
NPI 1740445642 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 32 payments from 13 companies in 2025. Trend: 2023 $112 · 2024 $488 · 2025 $558
Food & beverage: $545Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $89 |
| Gilead Sciences, Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $35 |
| Janssen Biotech, Inc. | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| QOL Medical, LLC | 1 | $32 |
| Ardelyx, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 3 | $30 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
Products named: LINZESS, RINVOQ, ENTYVIO, DUPIXENT, TREMFYA, IQIRVO, Sucraid, IBSRELA.
Industry payments across NY — which companies pay providers there.
